Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|May 30, 2007
Co-crystal structure guided array synthesis of PPARgamma inverse agonistsRyan P Trump, Jeffrey E Cobb, Barry G Shearer, et al.Toxicologic Pathology|December 11, 2024
International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular TissuesK A Schafer, E Atzpodien, U Bach, et al.Neurospine|July 4, 2020
Personal Health of Spine Surgeons Can Impact Perceptions, Decision-Making and Healthcare Delivery During the COVID-19 Pandemic - A Worldwide StudyArash J Sayari, Garrett K Harada, Philip K Louie, et al.JOR Spine|January 4, 2021
COVID-19: Current and future challenges in spine care and education - a worldwide studyMichael T Nolte, Garrett K Harada, Philip K Louie, et al.Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroupsSteven M Sparks, Pierette Banker, David M Bickett, et al.Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.Acta Crystallographica. Section D, Biological Crystallography|December 14, 2006
Crystallization of protein-ligand complexesAnne M Hassell, Gang An, Randy K Bledsoe, et al.Toxicologic Pathology|February 24, 2018
Characterizing Adversity of Lysosomal Accumulation in Nonclinical Toxicity Studies: Results from the 5th ESTP International Expert WorkshopB Lenz, A Braendli-Baiocco, J Engelhardt, et al.Journal of Medicinal Chemistry|January 5, 2019
5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site InhibitorsKevin M Peese, Christopher W Allard, Timothy Connolly, et al.Pageof 13